Informatics

The goal of health informatics systems is to enable smooth transfer of data and cybersecurity across the healthcare enterprise. This includes patient information, images, subspecialty reporting systems, lab results, scheduling, revenue management, hospital inventory, and many other health IT systems. These systems include the electronic medical record (EMR) admission discharge and transfer (ADT) system, hospital information system (HIS), radiology picture archiving and communication systems (PACS), cardiovascular information systems (CVIS), archive solutions including cloud storage and vendor neutral archives (VNA), and other medical informatics systems.

Quantum computer superconductivity

Quantum healthcare computing coiled for liftoff on US soil

The first quantum computer set up to support healthcare research in the United States has been delivered.

Cynthia Rudin, PhD. Photo courtesy of Duke University.

Prominent tech scholar: AI ‘feels like a runaway train that we’re chasing on foot’

Cynthia Rudin, PhD, is a highly regarded computer scientist who’s been eyeing the advance of artificial intelligence into society with equal parts enthusiasm and concern.  

Researchers building ‘commonsense AI’ from baby’s mind up

The project may inform theories of human neurodevelopment as dynamically as it advances computer and data science.

Rankings of radiology IT solutions by end-users in the 2023 Best in KLAS program

End-users of various radiology IT systems offer their assessment of the software in the annual KLAS Research 2023 Best in KLAS report.

KLAS 2023 rankings for cardiovascular information systems and hemodynamic solutions

Hospital end-users ranked the CVIS and hemodynamic systems they are using and shed light on their working relationships with IT vendors. 

The integration of artificial intelligence (AI) into radiology PACS and enterprise imaging systems has become a big topic of discussion with IT vendors over the past couple years. This has become a bigger question from hospitals and radiology groups as there are now about 400 radiology related AI algorithms that have U.S. Food and Drug Administration (FDA) clearance. Amy Thompson, a senior analyst at Signify Research, is monitoring AI trends in radiology and discusses trends.

Trends in the adoption and integration of AI into radiology workflows

Amy Thompson, a senior analyst at Signify Research, explains why AI adoption has been slow in radiology, common barriers and trends in the market.

Why is cloud computing is being adopted in radiology? Amy Thompson, a senior analyst at Signify Research, explains what she is seeing in radiology PACS and enterprise imaging system in the market in terms of cloud adoption. She said there has been rising interest in adopting cloud over the past few years, and the COVID pandemic showed amity healthcare systems the value of having a cloud-based system for easier remote access to patient data and imaging.

Cloud storage helps solve radiology IT and cybersecurity issues and is growing

Amy Thompson, a senior analyst at Signify Research, explains why radiology is rapidly adopting cloud data storage solutions.

 

An example of artificial intelligence (AI) automated detection of a intracranial hemorrhage (ICH) in. a CT scan used to send alerts to the stroke acute care team before a radiologist even sees the exam. Example shown by TeraRecon at RSNA 2022.

FDA has now cleared more than 500 healthcare AI algorithms

More than 500 clinical AI algorithms have now been cleared by the FDA, with the majority just in the past couple years.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.